Innoviva, Inc. (INVA) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $1.7 billion, Innoviva, Inc. is a small-cap company. The stock currently trades at $22.83, down 0.57% today, with a 52-week range of $16.52–$25.15. The company trades at a trailing P/E of 13.8x and a forward P/E of 10.2x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $3.30 | $4.02 | +816.7% | |
| 2024 | $0.36 | $0.37 | -83.6% | |
| 2023 | $2.20 | $2.75 | -7.2% | |
| 2022 | $2.37 | $3.07 | -17.4% | |
| 2021 | $2.87 | $3.24 | +42.1% | |
| 2020 | $2.02 | $2.21 | +381.0% | |
| 2019 | $0.42 | $0.45 | -82.1% | |
| 2018 | $2.34 | $2.61 | +368.0% | |
| 2017 | $0.50 | $0.55 | -5.7% | |
| 2016 | $0.53 | $0.54 | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — | |
| 2012 | — | — | — | |
| 2011 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-25 | 0001193125-26-071776 | SEC ↗ |
| 2024-12-31 | 2025-02-26 | 0000950170-25-027864 | SEC ↗ |
| 2023-12-31 | 2024-02-29 | 0000950170-24-023237 | SEC ↗ |
| 2022-12-31 | 2023-02-28 | 0000950170-23-005168 | SEC ↗ |
| 2021-12-31 | 2022-02-28 | 0000950170-22-002169 | SEC ↗ |
| 2020-12-31 | 2021-02-25 | 0001104659-21-028328 | SEC ↗ |
| 2019-12-31 | 2020-02-19 | 0001104659-20-022807 | SEC ↗ |
| 2018-12-31 | 2019-02-19 | 0001047469-19-000541 | SEC ↗ |
| 2017-12-31 | 2018-02-23 | 0001047469-18-001016 | SEC ↗ |
| 2016-12-31 | 2017-02-28 | 0001047469-17-001057 | SEC ↗ |
| 2015-12-31 | 2016-02-24 | 0001047469-16-010381 | SEC ↗ |
| 2014-12-31 | 2015-02-27 | 0001047469-15-001415 | SEC ↗ |
| 2013-12-31 | 2014-03-03 | 0001047469-14-001691 | SEC ↗ |
| 2012-12-31 | 2013-02-26 | 0001047469-13-001704 | SEC ↗ |